Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

BACKGROUND: This retrospective observational study validated nuclear grading criteria developed to identify a high-risk group with recurrence rate ≥20–30% and local pathology diagnosis used in a previous multi-institutional randomized N·SAS-BC 01 trial, where the efficacy of adjuvant chemotherapy re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Hitoshi, Kurosumi, Masafumi, Akiyama, Futoshi, Ohno, Shinji, Saji, Shigehira, Masuda, Norikazu, Shimomura, Akihiko, Sato, Nobuaki, Takao, Shintaro, Ohsumi, Shozo, Tokuda, Yutaka, Inaji, Hideo, Watanabe, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225977/
https://www.ncbi.nlm.nih.gov/pubmed/35435571
http://dx.doi.org/10.1007/s12282-022-01350-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225977/
https://www.ncbi.nlm.nih.gov/pubmed/35435571
http://dx.doi.org/10.1007/s12282-022-01350-4

Ejemplares similares